Status:
COMPLETED
Effentora® in Clinical Practice - a Non-interventional Study to Evaluate Satisfaction and Tolerability
Lead Sponsor:
Cephalon
Conditions:
Cancer
Pain
Eligibility:
All Genders
18+ years
Brief Summary
Aim of this non-interventional study is to investigate the tolerability of Effentora® in cancer pain patients with breakthrough pain under real-life conditions in clinical practice.
Detailed Description
In addition to the effectiveness of Effentora® therapy, safety, general feasibility and the impact of therapy on the patients' quality of life are of interest.
Eligibility Criteria
Inclusion
- decision to start treatment with Effentora
- prescription in accordance with Summary of Product Characteristics (SmPC)
- personally signed and dated Informed Consent document
Exclusion
- any subject considered unsuitable according to SmPC
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT01400854
Start Date
July 1 2011
End Date
October 1 2012
Last Update
October 24 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cephalon GmbH
Munich, Bavaria, Germany, 80339